These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1431368)

  • 1. [Clinical studies on the treatment of Campylobacter enteritis--emergence of quinolone-resistant Campylobacter jejuni after treatment with new quinolones].
    Obana M; Matsuoka Y; Irimajiri S; Tonooka H
    Kansenshogaku Zasshi; 1992 Jul; 66(7):923-9. PubMed ID: 1431368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of clinical efficacy of rokitamycin (RKM) and ofloxacin (OFLX) for the treatment of Campylobacter enteritis by a double-blind method. The Research Committee for the Effect of Rokitamycin, Research Group for Infectious Enteritis].
    Obana M; Tomizawa I; Takizawa Y; Nitta Y; Sagara H; Seo T; Sato J; Tsunoda T; Ota S; Machii A
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1165-82. PubMed ID: 1761896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics.
    Endtz HP; Broeren M; Mouton RP
    Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):48-50. PubMed ID: 8462563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
    Trajkovska-Dokic E; Mihajlov K; Mirchevska G; Kostovski M; Blazevska A; Stojkovska S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):73-80. PubMed ID: 31605592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical experience of rokitamycin on Campylobacter enteritis. Research Group of Rokitamycin on Infectious Enteritis].
    Irimajiri S; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Sato J; Tsunoda T; Ota S; Nakamura Y
    Kansenshogaku Zasshi; 1991 Sep; 65(9):1153-64. PubMed ID: 1761895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Chida T; Nakaya R
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibilities of Campylobacter strains isolated from broilers in the southern part of Japan from 1995 to 1999.
    Chuma T; Ikeda T; Maeda T; Niwa H; Okamoto K
    J Vet Med Sci; 2001 Sep; 63(9):1027-9. PubMed ID: 11642273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates.
    Ruiz J; Goñi P; Marco F; Gallardo F; Mirelis B; Jimenez De Anta T; Vila J
    Microbiol Immunol; 1998; 42(3):223-6. PubMed ID: 9580533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone and Macrolide-Resistant
    Abbasi E; van Belkum A; Ghaznavi-Rad E
    Microb Drug Resist; 2019 Sep; 25(7):1080-1086. PubMed ID: 31021299
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.
    Tee W; Mijch A; Wright E; Yung A
    Clin Infect Dis; 1995 Sep; 21(3):634-8. PubMed ID: 8527556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
    Smith KE; Besser JM; Hedberg CW; Leano FT; Bender JB; Wicklund JH; Johnson BP; Moore KA; Osterholm MT
    N Engl J Med; 1999 May; 340(20):1525-32. PubMed ID: 10332013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of susceptibilities of Campylobacter jejuni isolated from diarrhoeal cases to fluoroquinolones in Tokyo].
    Tadano K; Shingaki M; Saito K; Takahashi M; Kai A; Yanagawa Y; Itoh T; Ohta K; Kudoh Y
    Kansenshogaku Zasshi; 1996 Dec; 70(12):1227-33. PubMed ID: 9011115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli.
    Harnett N; McLeod S; Yong YA; Hewitt C; Vearncombe M; Krishnan C
    J Antimicrob Chemother; 1995 Jul; 36(1):269-70. PubMed ID: 8537280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
    Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C; Hogan T; White P; Tapsall J
    Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.
    Rautelin H; Renkonen OV; Kosunen TU
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2065-9. PubMed ID: 1759828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo.
    Bakeli G; Sato K; Kumita W; Saito R; Ono E; Chida T; Okamura N
    J Infect Chemother; 2008 Oct; 14(5):342-8. PubMed ID: 18936886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].
    Aoki T; Matsubara Y; Sagara H; Tomizawa I; Takizawa Y; Nitta Y; Seo T; Kamimura M; Masuda G; Negishi M
    Kansenshogaku Zasshi; 1989 Jun; 63(6):593-605. PubMed ID: 2693541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
    Žemličková H; Jakubů V; Marejková M; Urbášková P
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin.
    Wretlind B; Strömberg A; Ostlund L; Sjögren E; Kaijser B
    Scand J Infect Dis; 1992; 24(5):685-6. PubMed ID: 1465591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.